| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/28/2007 | CA2630704A1 Pharmaceutical composition |
| 06/28/2007 | CA2629991A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/28/2007 | CA2629984A1 New compounds |
| 06/28/2007 | CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | CA2628596A1 Estrogen modulators |
| 06/28/2007 | CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/28/2007 | CA2626764A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
| 06/28/2007 | CA2626234A1 Compressed solid dosage forms with drugs of low solubility and process for making the same |
| 06/28/2007 | CA2626220A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| 06/28/2007 | CA2618272A1 Pure rocuronium bromide |
| 06/28/2007 | CA2611737A1 Formulations containing glimepiride and/or its salts |
| 06/28/2007 | CA2602042A1 Kit and composition of imidazole with enhanced bioavailability |
| 06/27/2007 | EP1801231A1 Method of screening baff suppressor or inhibitor |
| 06/27/2007 | EP1801226A2 Arachidonic acid and methods for the production and use thereof |
| 06/27/2007 | EP1801218A2 Nucleic acids and proteins from streptococcus pneumoniae |
| 06/27/2007 | EP1801193A1 Process for producing concentrate of unsaturated fatty acid |
| 06/27/2007 | EP1801115A1 Cyclic peptides and their use in treating advanced stage neuroblastoma |
| 06/27/2007 | EP1801112A1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 06/27/2007 | EP1801111A1 Novel polymorph forms of olmesartan medoxomil |
| 06/27/2007 | EP1801110A1 Esomeprazole arginine salt |
| 06/27/2007 | EP1801108A1 Morpholine compound |
| 06/27/2007 | EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 06/27/2007 | EP1801104A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions |
| 06/27/2007 | EP1801103A1 Preparation of 2-((2,3- dihydro-benzo(1,4) dioxin-5-YL)-(2-hydroxyethyl)-amino)-ethanol and related intermediates |
| 06/27/2007 | EP1801098A1 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors |
| 06/27/2007 | EP1800713A1 Use of alkoxylates of monovalent and polyvalent alcohols or a derivative thereof as substituent antibioticum in animal feed |
| 06/27/2007 | EP1800691A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 06/27/2007 | EP1800687A2 Anionic polymers as toxin binders and antibacterial agents |
| 06/27/2007 | EP1800686A2 Anionic polymers as toxin binders and antibacterial agents |
| 06/27/2007 | EP1800685A1 Steroidal saponin pharmaceutical composition, its preparation method and use |
| 06/27/2007 | EP1800684A1 Novel alkyl phospholipid derivatives and uses thereof |
| 06/27/2007 | EP1800683A1 New association of an If sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association |
| 06/27/2007 | EP1800682A1 Medicinal composition for prevention or treatment of parasitic protozoan infection |
| 06/27/2007 | EP1800681A1 SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE THIAZOLYL METHYL ESTER OF [5S-(5R*,8R*,10R*,11R*)]-10-HYDROXY-2-METHYL-5-(1-METHYLETHYL)-1-[2-1(1-METHYLETHYL)-4-THIAZOLYL]-3,6-DIOXO-8,11-BIS(PHENYLMETHYL)-2,4,7,12-TETRAAZATRIDECAN-13-OIC ACID AND PREPARATION METHOD THEREOFvvv |
| 06/27/2007 | EP1800680A1 Cerebral infarction suppressant |
| 06/27/2007 | EP1800679A2 Nonsedating A-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione |
| 06/27/2007 | EP1800678A1 Combination of an inhibitor of the If current of the sinus node and an inhibitor of the angiotensin converting enzyme |
| 06/27/2007 | EP1800677A1 Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction |
| 06/27/2007 | EP1800676A1 Cancer chemotherapy |
| 06/27/2007 | EP1800675A1 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 06/27/2007 | EP1800674A1 Agent for preventing metabolic syndrome |
| 06/27/2007 | EP1800673A2 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 06/27/2007 | EP1800672A1 Pharmaceutical composition and the use therof for the treatment of dermatoses |
| 06/27/2007 | EP1800670A1 Micellar drug delivery systems for hydrophobic drugs |
| 06/27/2007 | EP1800669A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine |
| 06/27/2007 | EP1800668A1 Process for the manufacture of particles containing antibotics and their application |
| 06/27/2007 | EP1800667A1 Rapidly solubilizing ibuprofen granulate |
| 06/27/2007 | EP1800666A1 Nanoparticulate compositions of angiogenesis inhibitors |
| 06/27/2007 | EP1800665A2 Submicron liposome suspensions obtained from preliposome lyophilizates |
| 06/27/2007 | EP1800664A1 Pharmaceutical formulations for parenteral administration comprising epothilone |
| 06/27/2007 | EP1800134A2 Method for diagnosing and treating crohn's disease |
| 06/27/2007 | EP1799866A2 Modulating mxa expression |
| 06/27/2007 | EP1799828A2 Biosynthesis of philoroglucinol and preparation of 1,3-dihydroxybenzene therefrom |
| 06/27/2007 | EP1799825A2 Aptamer regulated nucleic acids and uses thereof |
| 06/27/2007 | EP1799759A1 4-phenylbutyric acid controlled-release formulations for therapeutic use |
| 06/27/2007 | EP1799709A1 Myostatin isoform |
| 06/27/2007 | EP1799699A1 Analogs of 17-hydroxywortmannin as pi3k inhibitors |
| 06/27/2007 | EP1799698A1 Bioreductively-activated prodrugs |
| 06/27/2007 | EP1799696A2 Phosphoindoles as hiv inhibitors |
| 06/27/2007 | EP1799695A1 New process for the preparation of alkyl phosphinic acids |
| 06/27/2007 | EP1799691A1 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors |
| 06/27/2007 | EP1799690A1 Thiazolyl-dihydro indazoles |
| 06/27/2007 | EP1799689A1 Furazano `3, 4-b ! pyrazynes and their use as anti-tumor agents |
| 06/27/2007 | EP1799687A1 Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 06/27/2007 | EP1799686A1 Bioreductively-activated prodrugs |
| 06/27/2007 | EP1799685A2 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 06/27/2007 | EP1799684A2 Lactam compounds useful as protein kinase inhibitors |
| 06/27/2007 | EP1799683A1 Hexahydro-pyrazino[1,2-a]pyrimidine-4, 7-dione derivatives substituted with amino acids |
| 06/27/2007 | EP1799682A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/27/2007 | EP1799681A1 Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders |
| 06/27/2007 | EP1799679A1 N,n'-dithenylurea derivatives used in the form of kinase inhibitors |
| 06/27/2007 | EP1799678A1 Process for preparing ziprasidone |
| 06/27/2007 | EP1799677A1 Oxazolidinone derivatives as antimicrobials |
| 06/27/2007 | EP1799674A1 New piperidine antibiotics |
| 06/27/2007 | EP1799673A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 06/27/2007 | EP1799672A2 Cgrp receptor antagonists |
| 06/27/2007 | EP1799671A2 Chemical compounds |
| 06/27/2007 | EP1799670A1 Benzoimidazole derivatives useful as antiproliferative agents |
| 06/27/2007 | EP1799669A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 06/27/2007 | EP1799668A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 06/27/2007 | EP1799666A2 Piperidine derivatives as nk1 antagonists |
| 06/27/2007 | EP1799664A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 06/27/2007 | EP1799663A1 Modulators of hcv replication |
| 06/27/2007 | EP1799662A2 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| 06/27/2007 | EP1799661A1 New hydroxymethylbenzothiazoles amides |
| 06/27/2007 | EP1799659A1 Compounds for nonsense suppression, and methods for their use |
| 06/27/2007 | EP1799653A2 Novel heterocycles |
| 06/27/2007 | EP1799652A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 06/27/2007 | EP1799651A2 Small molecule modulators of cytokine activity |
| 06/27/2007 | EP1799650A2 Imidazole derivatives as large conductance calcium activated k channel openers |
| 06/27/2007 | EP1799649A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators |
| 06/27/2007 | EP1799648A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 06/27/2007 | EP1799647A1 Alkil-pyridines as 11-beta inhibitors for diabetes |
| 06/27/2007 | EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 06/27/2007 | EP1799644A1 Lercanidipine salts |
| 06/27/2007 | EP1799643A1 Indolone derivatives, processes for preparing them and their uses |
| 06/27/2007 | EP1799642A1 Process and intermediates for the selective synthesis of fluvastatin |
| 06/27/2007 | EP1799641A1 Process for the preparation of amorphous fluvastatin sodium |
| 06/27/2007 | EP1799640A2 Indole compounds useful as serotonin selective agents |
| 06/27/2007 | EP1799639A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |